Food & Health
Law & Insurance
Nano & Biomaterials
Markets & Trends
Welcome to the
European Life Science Journal for international business
Get inspired by the entrepreneurs leading the way of tomorrow´s life science businesses !
BIO: debating value in Chicago
At the BIO International convention in Chicago, analysts have reported strong performance from the global biotech sector.They pointed out that there is an urgent need for the industry to demonstrate value of products under development. For 2012, Ernst & Young’s industry report “Beyond borders” reports an increase in revenues by 8% to US$ 89.8bn, with the net income of US$5.2 bn, representi...
Horizon teams up with AstraZeneca
AstraZeneca has exclusively licenced Horizon Discoverys kinase target programme.Horizon Discovery and AstraZeneca have entered into an exclusive collaboration and license agreement to explore Hori...
Trial success for Lundbeck
In a thorough comparison, Lundbecks new antidepressant Brintellix shone brightly: On a system for rating depression patients performed better.Danish H. Lundbeck A/S reported on positive results fo...
AstraZeneca fails endpoint
AstraZenecas arthritis pill fostamatinib is proven inferior to competitor drugs in a late-stage clinical trial.While the first-in-class oral rheumatoid (RA) arthritis drug proved to be efficient a...
Clavis 2nd lead failed
Clavis Pharma has become a target for a take-over after its cancer drug delivery technology failed proof-of-concept for the second time.In November, US partner Clovis Oncology said it will termina...
British Shire plc has broadened its therapeutic scope to neonatology by the strategic acquisition of Swedish Premacure AB of Uppsala.
The privately held biotech company is running a dose finding, safety and efficacy Phase II programme for the most common cause of visual loss in childhood – the prevention of retinopathy of prematu...
Active Biotech raises €32.4m
SwedishActive Biotech has issued new shares to obtain money for its clinicalautoimmunity and cancer programmes. 0 false 21 18 pt 18 pt 0 0 false false false ...
Experts explore the key success factors for portfolio planning and LCM
SMi’s Pharmaceutical Portfolio and Lifecycle Management conference returns to London in April for the 8th year running. The expert speakers will explore and debate the key succe...
The latest breakthroughs in adaptive designs to be disclosed
Clinical trials run by pharmaceutical and biotech companies have undergone major changes, implementing adaptive designs to tailor a trial. Reduction in costs and timings of early phase ...
Biofuels producers join forces
Seven leading producers of second generation biofuels have joined forces in anindustry initiative to support uptake of their technology.The initiative,named “Leaders of Sustainable Biofuels”, aims...